- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 6, 2025 | 63.56M sh |
| Short Term Investments | Q1 2025 · Feb 2, 2025 | $0 |
| Short Term Investments | Q1 2025 · Oct 31, 2024 | $42.18M |
| Stockholders Equity | Q1 2025 · Feb 2, 2025 | $1.13B |
| Stockholders Equity | Q1 2025 · Oct 31, 2024 | $1.12B |
| Current Liabilities | Q1 2025 · Feb 2, 2025 | $162.64M |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $183.81M |
| Total Liabilities | Q1 2025 · Feb 2, 2025 | $210.46M |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $231.3M |
| Current Assets | Q1 2025 · Feb 2, 2025 | $920.83M |
| Current Assets | Q1 2025 · Oct 31, 2024 | $931.06M |
| Total Assets | Q1 2025 · Feb 2, 2025 | $1.7B |
| Total Assets | Q1 2025 · Oct 31, 2024 | $1.71B |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $598.49M |
| Cash And Equivalents | Q1 2025 · Jan 28, 2024 | $508.52M |
| Shares Diluted | Q1 2025 · Jan 28, 2024 | 62.28M sh |
| Stock Repurchased | Q1 2025 · Jan 28, 2024 | $0 |
| Capex | Q1 2025 · Jan 28, 2024 | $43.31M |
| Operating Cash Flow | Q1 2025 · Jan 28, 2024 | $41.51M |
| Eps Diluted | Q1 2025 · Jan 28, 2024 | $0.42 |
| Eps Basic | Q1 2025 · Jan 28, 2024 | $0.43 |
| Sga Expense | Q1 2025 · Jan 28, 2024 | $18.32M |
| Rd Expense | Q1 2025 · Jan 28, 2024 | $3.45M |
| Net Income | Q1 2025 · Jan 28, 2024 | $26.18M |
| Operating Income | Q1 2025 · Jan 28, 2024 | $57.49M |
| Gross Profit | Q1 2025 · Jan 28, 2024 | $79.26M |
| Cost Of Revenue | Q1 2025 · Jan 28, 2024 | $137.08M |
| Revenue | Q1 2025 · Jan 28, 2024 | $216.33M |